# Completion Report: hpw-who-icc-references-integration

**Feature**: `hpw-who-icc-references-integration`
**Status**: COMPLETED
**Match Rate**: 100%
**Iterations**: 0
**Date**: 2026-03-06

---

## Executive Summary

Two authoritative myeloid classification reference files (`2022_WHO_MyeloidClassificationDefinition.md` and `2022_ICC_MyeloidClassificationDefinition.md`) that existed in the HPW skill's `references/` directory but were undiscoverable have been wired into the skill via two targeted edits. Claude can now load these files on demand when writing disease classification content, and the `ClassificationValidator` skill class is linked to its source of truth.

**Total code delta**: +27 lines across 2 files. Zero new files created.

---

## What Was Built

### Path 1 — SKILL.md Reference Files table (+3 lines)

Two rows added to the `## Reference Files` table:

```markdown
| `references/2022_WHO_MyeloidClassificationDefinition.md` | WHO 2022 diagnostic criteria for all myeloid entities (AML blast thresholds, MDS, MPN, CML, CHIP). Load when writing disease classification or definition sections, verifying entity names, blast percentages, or molecular criteria per WHO 2022. |
| `references/2022_ICC_MyeloidClassificationDefinition.md` | ICC 2022 diagnostic criteria. Load alongside the WHO file when documenting WHO vs ICC divergence: CML accelerated phase (ICC-only), AML with NPM1 blast threshold (any% WHO vs ≥10% ICC), or MDS naming ("Neoplasms" WHO vs "Syndromes" ICC). |
```

### Path 2 — scientific-skills.md Classification Reference Files section (+24 lines)

New `## Classification Reference Files` section inserted before `## Part 20`, containing:
- File table linking WHO/ICC files to the `ClassificationValidator` skill class
- 4-row divergence table covering the most clinically significant WHO vs ICC differences

---

## PDCA Phase Summary

| Phase | Output | Status |
|-------|--------|--------|
| Plan | `docs/01-plan/features/hpw-who-icc-references-integration.plan.md` | ✅ |
| Design | `docs/02-design/features/hpw-who-icc-references-integration.design.md` | ✅ |
| Do | 2 file edits (SKILL.md + scientific-skills.md) | ✅ |
| Check | `docs/03-analysis/hpw-who-icc-references-integration.analysis.md` — 100% | ✅ |
| Act | Not required (100% match rate) | — |

---

## Files Modified

| File | Change | Lines Before → After |
|------|--------|----------------------|
| `hematology-paper-writer/SKILL.md` | +2 Reference Files table rows | 101 → 104 |
| `hematology-paper-writer/references/scientific-skills.md` | +Classification Reference Files section | 59 → 83 |

---

## Key Divergences Now Documented

| Divergence | WHO 2022 | ICC 2022 |
|------------|----------|----------|
| CML Accelerated Phase | Not recognized | 10–19% blasts or ACA in Ph+ cells |
| AML with NPM1 mutation | Any blast % | ≥10% blasts |
| MDS category name | "Myelodysplastic Neoplasms" | "Myelodysplastic Syndromes" |
| Clonal Haematopoiesis | CHIP/CCUS (top-level) | Not a top-level ICC category |

---

## Design Decisions

- **Independent files, not merged**: WHO and ICC files remain separate so manuscripts targeting one system don't load noise from the other
- **Scoped triggers**: WHO row targets classification/definition sections; ICC row specifically targets divergence scenarios — avoids loading both files for pure literature search tasks
- **CSA excluded**: ELN 2022 AML risk stratification (CSA domain) is distinct from WHO/ICC diagnostic classification — no CSA changes warranted
